Home
SAiGENCI is an independent cancer-focused medical research institute located in South Australia; focusing on cancer research and linking to clinical trials, which include new cutting-edge technologies in immunotherapies and genomics.
Help make cancer history
100% of your gift will support leading-edge cancer research, which will lead to better outcomes for patients with cancer, and their families.
With your support, we can save lives.
Sign up to our mailing list
Keep up to date with how we are changing the future of cancer treatment.
Featured projects
Winning the ‘chess’ game against cancer
How a powerful computer modelling approach could predict cancer’s “next move” when faced with targeted treatments.
Read more about Winning the ‘chess’ game against cancer
Developing the first drug for multi-organ radiation protection
A pharmaceutical breakthrough at the University of Adelaide is showing promise in both multi-organ radiation protection and cancer treatment.
Read more about Developing the first drug for multi-organ radiation protectionLeadership appointments
Professor Christopher Sweeney
Professor Christopher Sweeney is SAiGENCI's inaugural Director.
Professor Lisa Butler
Professor Lisa Butler is Program Lead for the Resistance Prevention program. She also leads SAiGENCI’s Graduate Program for HDR and Honours students.
Professor Brendan Jenkins
Professor Brendan Jenkins is Program Lead for the Tumour Inflammation and Immunotherapy program.
Professor Lan Nguyen
Professor Lan Nguyen is Program Lead for the Computational Systems Oncology program.
Professor Jose Polo
Professor Jose Polo is Program Lead for Cancer Epigenetics in SAiGENCI, building the epigenetics capacity within the Institute. Professor Polo has established the Adelaide Centre for Epigenetics (ACE).
News
04 Nov
Viertel Fellowship for innovative cancer epigentic leader
University of Adelaide cancer epigenetics and 3D genome biology expert Dr Joanna Achinger-Kawecka has been awarded a 2025 Sylvia and Charles Viertel Senior Medical Research Fellowship. 30 Oct
Professor Jose Polo elected Fellow of the Australian Academy of Health and Medical Sciences (AAHMS)
SAiGENCI are proud to announce Professor Jose Polo has been elected as Fellow of the Australian Academy of Health and Medical Sciences (AAHMS).
Events
30 Jan
The Adelaide Cancer Seminar Series
The Adelaide Cancer Seminar Series are jointly organised by the South Australian immunoGENomics Cancer Institute (SAiGENCI), Centre for Cancer Biology (CCB) and the South Australian Health and Medical Research Institute (SAHMRI). The aim of the seminar series is to forge links across the research community, foster collaborative links between the researchers within Australia and internationally and to showcase outstanding research being conducted around Australia by top scientists.
